BNTC icon

Benitec Biopharma

30 hedge funds and large institutions have $240M invested in Benitec Biopharma in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$27.1M
2 +$22.1M
3 +$14.3M
4
BlackRock
BlackRock
New York
+$1.84M
5
SCM
Suvretta Capital Management
New York
+$1.65M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$113M
2
$37.1M
3
$33.3M
4
$24.9M
5
$10.6M
6
$3.79M
7
$3.29M
8
$2.65M
9
$2.49M
10
$2.19M
11
$1.29M
12
$964K
13
$783K
14
$632K
15
$535K
16
$482K
17
$452K
18
$448K
19
$313K
20
$264K
21
$203K
22
$157K
23
$81.4K
24
$63.3K
25
$13.9K